Marché potentiel mondial des tests de dépistage salivaire COVID-19 – Tendances et prévisions de l'industrie jusqu'en 2028

Analyse et perspectives du marché : marché potentiel mondial des tests de dépistage salivaire de la COVID-19

Data Bridge Market Research analyse que le marché potentiel des tests de dépistage salivaire COVID-19 représentera 4 138,40 millions USD d'ici 2028 et croîtra à un TCAC de 7,23 % au cours de la période de prévision 2021-2028.

Le test salivaire antigénique/anticorps COVID-19 permet d'identifier rapidement les personnes activement contagieuses et constitue une modalité de dépistage efficace pour les navires de croisière, les avions, les stades de sport et les universités. La combinaison de la vaccination et d'un test rapide et fréquent de dépistage des antigènes/anticorps COVID-19 par la salive présente un potentiel prometteur pour mettre fin à la pandémie.

Les défis liés au calendrier et à l'évolutivité des tests SARS-CoV-2 basés sur des écouvillons moléculaires sont des facteurs clés qui incitent les consommateurs à se tourner vers des approches de test/dépistage basées sur la salive, augmentant ainsi la croissance du marché. L'émergence de variants du SARS-CoV-2 en Afrique du Sud, au Royaume-Uni et au Brésil, qui se sont révélés plus transmissibles que la souche d'origine, renforce le besoin de tests rapides.

Alors que le nombre de personnes fréquentant les lieux publics augmente et atteint les statistiques d'avant la pandémie dans certains pays, la demande de tests COVID-19 rapides et au point de service augmente pour atténuer la transmission d'agents infectieux à partir de personnes asymptomatiques.

Cela a augmenté la recherche et le développement pour le développement de tests salivaires simples mais efficaces et devrait créer des opportunités lucratives pour de nombreux développeurs. Cependant, la forte pénétration des méthodes de test par écouvillonnage et les limitations liées à l'approche méthodologique entraveront la croissance du marché.

This COVID-19 saliva screening test potential market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on COVID-19 saliva screening test potential Market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global COVID-19 Saliva Screening Test Potential Market Scope and Market Size

The COVID-19 saliva screening test potential market is segmented on the basis of location, technology, and mode. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• Based on location, the COVID-19 saliva screening test potential market is segmented into travel stations, sports arenas, entertainment venues, corporate campus environments, universities and colleges, factories and others.
• On the basis of technology, the COVID-19 saliva screening test potential market is segmented into fluorescence-labeled antigen/antibodies testing, RT-PCR and CRISPR-Cas9.
• On the basis of mode, the COVID-19 saliva screening test potential Market is segmented into centralized testing and decentralized testing.

COVID-19 Saliva Screening Test Potential Market Country Level Analysis

The COVID-19 saliva screening test potential market is segmented on the basis of location, technology, and mode.

The countries covered in the COVID-19 saliva screening test potential Market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the COVID-19 saliva screening test potential market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of major players, high healthcare expenditure and rising use of technological advance devices in hospitals in this region. Europe on the other hand is projected to exhibit the highest growth rate during the forecast period due to the growing awareness about COVID-19 saliva screening test changing lifestyle, and increasing population in this region.

The country section of the COVID-19 saliva screening test potential market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The COVID-19 saliva screening test potential market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for COVID-19 saliva screening test potential market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the COVID-19 saliva screening test potential market. The data is available for historic period 2010 to 2019.

Competitive Landscape and COVID-19 Saliva Screening Test Potential Market Share Analysis

The COVID-19 saliva screening test potential market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to COVID-19 saliva screening test potential market.

Les principaux acteurs couverts dans le rapport sur le marché potentiel des tests de dépistage salivaire COVID-19 sont ARUP Laboratories, Vatic Health, MOgene, Psomagen, Inc., DxTerity Diagnostics, Inc., Ambry Genetics, Fluidigm Corporation, Gravity Diagnostics, DNA Genotek, Inc., Quidel Corporation, Abbott, LumiraDX, FluroTech Ltd, entre autres acteurs nationaux et mondiaux. Les données sur les parts de marché sont disponibles séparément pour le monde, l'Amérique du Nord, l'Europe, l'Asie-Pacifique (APAC), le Moyen-Orient et l'Afrique (MEA) et l'Amérique du Sud. Les analystes de DBMR comprennent les atouts concurrentiels et fournissent une analyse concurrentielle pour chaque concurrent séparément.

SKU-66592